selected scholarly activity
-
conferences
- Development of a Monolithic Chromatography-Based Manufacturing Process for Clinical-Grade Viral Vectors. Molecular Therapy. 223-223. 2017
- 713. Optimization and Scale-Up of a Manufacturing Process for Clinical-Grade Adenovirus-Based Vectors. Molecular Therapy. S281-S281. 2016
- Development of a Manufacturing Process for an Oncolytic Vaccine. Human Gene Therapy. A49-A49. 2012
- Large-Scale Production of a Maraba-Based Oncolytic Virus. Molecular Therapy. S224-S224. 2012
- Anti-HIV-1 gene therapy. Transfusion and Apheresis Science. 109-120. 1996
-
journal articles
- Comparison of the performance of anion exchange membrane materials for adenovirus purification using laterally-fed membrane chromatography. Biochemical Engineering Journal. 182:108417-108417. 2022
- Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses. Membranes. 12:359-359. 2022
- Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell. 185:896-915.e19. 2022
- Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans. JCI insight. 7:e155655. 2022
- Probing effects of additives on the filterability of oncolytic viruses via a microfiltration process. Journal of Membrane Science. 620:118783-118783. 2021
- Integrated development of enzymatic DNA digestion and membrane chromatography processes for the purification of therapeutic adenoviruses. Separation and Purification Technology. 254:117503-117503. 2021
- Purification of therapeutic adenoviruses using laterally-fed membrane chromatography. Journal of Membrane Science. 579:351-358. 2019
- Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection. Mucosal Immunology. 8:1373-1387. 2015
- Modulation of pulmonary fibrosis by IL-13Rα2. American Journal of Physiology - Lung Cellular and Molecular Physiology. 308:L710-L718. 2015
- Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes. Molecular Therapy - Methods and Clinical Development. 1:5-5. 2014
- A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity. Science Translational Medicine. 5:205ra134. 2013
- IL-15 has innate anti-tumor activity independent of NK and CD8 T cells. Journal of Leukocyte Biology. 88:529-536. 2010
- Gene Therapy for Pulmonary Diseases. Chest. 130:879-884. 2006
- Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Molecular Therapy. 8:777-789. 2003
- RNA-polymerase III-driven expression cassettes in human gene therapy.. Current Opinion in Molecular Therapeutics. 1:580-594. 1999
- Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes. Nucleic Acids Research (NAR). 27:1698-1708. 1999
- Anti-HIV-1 Gene Therapy. Transfusion and Apheresis Science. 17:109-120. 1996